The FDA approval of Abbott's TactiFlex Ablation Catheter is a significant milestone for the company, as it is the world's first ablation catheter with a flexible tip and contact force technology. This approval could lead to increased demand for Abbott's products, as it offers a more efficient and safer treatment option for atrial fibrillation, a condition affecting millions of people worldwide. The approval also strengthens Abbott's market position in the medical device industry.